fansidar ( sp ) , a combination of sulfadoxine and pyrimethamine , was evaluated for its usefulness as a curative agent for treating individual malaria patients and for reducing the community reservoir of plasmodium falciparum in 4 villages near lahore , pakistan , where resistance of 4-aminoquinolines has recently been reported .
C0038679
sulfadoxine
C0024530
malaria